Member Info for inanaco

Have Fun ....

or another way of looking at the OO .,.. you are buying at a discount to current market giving you a capital gain ... only existing Scancell shareholders get that benefit

the stock market has already priced that in ........ with the share price above the conversion price

money has to be in the accounts otherwise you get nothing

this is all about T cell repertoire ... a naive T cell going active against the N protein's (epitope) inducing after infection a Memory T cell ...

Thus you have a repertoire for cells that can target the N protein

how does that apply to Moditope ?????

just to underline the importance of what Scancell discovered in patients blood that we do have a repertoire for Citrullinated Modi1 epitopes

we just need to activate them ......

and you could reverse this further .............

Scancells vaccine could potentially protect you from a cronovirus common cold ..

those vaccines only targeting the spike ... probably will not

broken down for you .........

The researchers gathered blood samples from 36 people who’d recently recovered from mild to severe COVID-19. They focused their attention on T cells (including CD4 helper and CD8 cytotoxic, both of which can function as memory T cells). They identified T cells that respond to the SARS-CoV-2 nucleocapsid, which is a structural protein inside the virus. They also detected T cell responses to two non-structural proteins that SARS-CoV-2 needs to make additional copies of its genome and spread. The team found that all those recently recovered from COVID-19 produced T cells that recognize multiple parts of SARS-CoV-2.

Finally, Bertoletti’s team looked for such T cells in blood samples from 37 healthy individuals with no history of either COVID-19 or SARS. To their surprise, more than half had T cells that recognize one or more of the SARS-CoV-2 proteins under study here. It’s still not clear if this acquired immunity stems from previous infection with coronaviruses that cause the common cold or perhaps from exposure to other as-yet unknown coronaviruses.

summary ........

Lindy and the team Get it ...........

hence don't rush out a vaccine ..

its not a debate its maths ....

you can try this at home

take the average price of orange juice over a period .... lets call it 5.5p per cubic mm.

fill the glass with the number of cubic mm relative to the number of shares in issue of scancell prior to the cash raise

then dilute it with the new number of shares in issue at the 5.5p per cubic mm price which we will call orange juice

then apply ....... taste the difference

is orange juice diluted with orange juice ... different or not

tough call .....

debates are based on both sides providing evidence ...

because we are overdosing on Orange juice .... the Sugar Rush ... could propel the Glycans ...

raise a glass ....

I mentioned before that Industry should get behind Scancell in developing Covidity .... BA's quarter loss dwarf's that cost .. and the GOV needs to think ... that loss is a carry forward against futures taxs ....

why are they dithering ... without GOV intervention multiple stage's of simultaneous development cannot happen ...

we missed your expert opinion on that one Ray...

I cannot access sorry ... unless i pay premium .

lets look at another alternative view by DE .....

"""My instinct is that there is significant investor fatigue - that combined with a challenging investment climate will make a further fundraising difficult thus highlighting the vulnerability of the Company to a takeover approach"""

so we have raised funds against that backdrop ... to find ourselves susceptible to a takeover again ?

mmmmmmmmm

Scancells research is funded ... and Indeed If Lindy had of felt that way inclined .. rather than taking a pay cut . They could have looked for a Take Over ...

Facts on the ground do not indicate your concerns

see how fast barclays can do a move ?

yes and try and buy 46m shares on the market ....

fascinating ......... 8 recs

The maximum they can hold is just under 217.5m before triggering rule 9 of the Takeover Code. That only leaves headroom of around 46m shares which sets a limit on how much Redmile can contribute to future funding rounds without being forced to make a mandatory offer for the Company.

that statement is not correct...

just so folks understand

because they can still participate without changing the % of ownership ........ thus the 46m widens

If scancell raise more funds from an Issue of shares .. then the headroom of 46m shares widens ...

bermuda you could say the same thing about any institutional buying ...

So David Evans was quite right to mention the issue, we should all be aware of any risks and beyond that, there's plenty of information out there, it's up to each one of us to do our own research and make our own judgement calls.

but without BOD support ...its hostile

Lozan and Tosh absorb yet another jelly spanner and get all excited ...

rather than observing that Redmile part funded BioNtech as a Private company that went Public ...

which is what most investors want ... a Stock market Listing .

I think NXC posted a jelly spanner ... just to wind them up ..

yep ...

the infection from covid becomes "chronic" .. that is when you need down regulation .. exactly my point ...

scancell spend there time trying to Up regulate ... producing Effector Cells .. as do all the vaccines